Pharma & Healthcare
Global Andrographolide Drug Market Research Report 2025
- Oct 04, 25
- ID: 525862
- Pages: 78
- Figures: 86
- Views: 8
Report Scope
This report aims to provide a comprehensive presentation of the global market for Andrographolide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Andrographolide Drug.
The Andrographolide Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Andrographolide Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Andrographolide Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Tasly Group
Furen Pharmaceutical
Jiuhui Pharmaceutical
Sunflower Pharmaceutical
Nanjing Zhengke Pharmaceutical
Livzon Pharm
HORMOSAN Pharma
Segment by Type
Capsule
Pill
Tablet
Segment by Application
Hospital Clinic
Pharmacy
Online Pharmacy
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Andrographolide Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Andrographolide Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Andrographolide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Andrographolide Drug.
The Andrographolide Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Andrographolide Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Andrographolide Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Tasly Group
Furen Pharmaceutical
Jiuhui Pharmaceutical
Sunflower Pharmaceutical
Nanjing Zhengke Pharmaceutical
Livzon Pharm
HORMOSAN Pharma
Segment by Type
Capsule
Pill
Tablet
Segment by Application
Hospital Clinic
Pharmacy
Online Pharmacy
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Andrographolide Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Andrographolide Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Andrographolide Drug Market Overview
1.1 Product Definition
1.2 Andrographolide Drug by Type
1.2.1 Global Andrographolide Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Capsule
1.2.3 Pill
1.2.4 Tablet
1.3 Andrographolide Drug by Application
1.3.1 Global Andrographolide Drug Market Value by Application (2024 VS 2031)
1.3.2 Hospital Clinic
1.3.3 Pharmacy
1.3.4 Online Pharmacy
1.4 Global Andrographolide Drug Market Size Estimates and Forecasts
1.4.1 Global Andrographolide Drug Revenue 2020-2031
1.4.2 Global Andrographolide Drug Sales 2020-2031
1.4.3 Global Andrographolide Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Andrographolide Drug Market Competition by Manufacturers
2.1 Global Andrographolide Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Andrographolide Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Andrographolide Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Andrographolide Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Andrographolide Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Andrographolide Drug, Product Type & Application
2.7 Global Key Manufacturers of Andrographolide Drug, Date of Enter into This Industry
2.8 Global Andrographolide Drug Market Competitive Situation and Trends
2.8.1 Global Andrographolide Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Andrographolide Drug Players Market Share by Revenue
2.8.3 Global Andrographolide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Andrographolide Drug Market Scenario by Region
3.1 Global Andrographolide Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Andrographolide Drug Sales by Region: 2020-2031
3.2.1 Global Andrographolide Drug Sales by Region: 2020-2025
3.2.2 Global Andrographolide Drug Sales by Region: 2026-2031
3.3 Global Andrographolide Drug Revenue by Region: 2020-2031
3.3.1 Global Andrographolide Drug Revenue by Region: 2020-2025
3.3.2 Global Andrographolide Drug Revenue by Region: 2026-2031
3.4 North America Andrographolide Drug Market Facts & Figures by Country
3.4.1 North America Andrographolide Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Andrographolide Drug Sales by Country (2020-2031)
3.4.3 North America Andrographolide Drug Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Andrographolide Drug Market Facts & Figures by Country
3.5.1 Europe Andrographolide Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Andrographolide Drug Sales by Country (2020-2031)
3.5.3 Europe Andrographolide Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Andrographolide Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Andrographolide Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Andrographolide Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Andrographolide Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Andrographolide Drug Market Facts & Figures by Country
3.7.1 Latin America Andrographolide Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Andrographolide Drug Sales by Country (2020-2031)
3.7.3 Latin America Andrographolide Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Andrographolide Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Andrographolide Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Andrographolide Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Andrographolide Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Andrographolide Drug Sales by Type (2020-2031)
4.1.1 Global Andrographolide Drug Sales by Type (2020-2025)
4.1.2 Global Andrographolide Drug Sales by Type (2026-2031)
4.1.3 Global Andrographolide Drug Sales Market Share by Type (2020-2031)
4.2 Global Andrographolide Drug Revenue by Type (2020-2031)
4.2.1 Global Andrographolide Drug Revenue by Type (2020-2025)
4.2.2 Global Andrographolide Drug Revenue by Type (2026-2031)
4.2.3 Global Andrographolide Drug Revenue Market Share by Type (2020-2031)
4.3 Global Andrographolide Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Andrographolide Drug Sales by Application (2020-2031)
5.1.1 Global Andrographolide Drug Sales by Application (2020-2025)
5.1.2 Global Andrographolide Drug Sales by Application (2026-2031)
5.1.3 Global Andrographolide Drug Sales Market Share by Application (2020-2031)
5.2 Global Andrographolide Drug Revenue by Application (2020-2031)
5.2.1 Global Andrographolide Drug Revenue by Application (2020-2025)
5.2.2 Global Andrographolide Drug Revenue by Application (2026-2031)
5.2.3 Global Andrographolide Drug Revenue Market Share by Application (2020-2031)
5.3 Global Andrographolide Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Tasly Group
6.1.1 Tasly Group Company Information
6.1.2 Tasly Group Description and Business Overview
6.1.3 Tasly Group Andrographolide Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Tasly Group Andrographolide Drug Product Portfolio
6.1.5 Tasly Group Recent Developments/Updates
6.2 Furen Pharmaceutical
6.2.1 Furen Pharmaceutical Company Information
6.2.2 Furen Pharmaceutical Description and Business Overview
6.2.3 Furen Pharmaceutical Andrographolide Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Furen Pharmaceutical Andrographolide Drug Product Portfolio
6.2.5 Furen Pharmaceutical Recent Developments/Updates
6.3 Jiuhui Pharmaceutical
6.3.1 Jiuhui Pharmaceutical Company Information
6.3.2 Jiuhui Pharmaceutical Description and Business Overview
6.3.3 Jiuhui Pharmaceutical Andrographolide Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Jiuhui Pharmaceutical Andrographolide Drug Product Portfolio
6.3.5 Jiuhui Pharmaceutical Recent Developments/Updates
6.4 Sunflower Pharmaceutical
6.4.1 Sunflower Pharmaceutical Company Information
6.4.2 Sunflower Pharmaceutical Description and Business Overview
6.4.3 Sunflower Pharmaceutical Andrographolide Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sunflower Pharmaceutical Andrographolide Drug Product Portfolio
6.4.5 Sunflower Pharmaceutical Recent Developments/Updates
6.5 Nanjing Zhengke Pharmaceutical
6.5.1 Nanjing Zhengke Pharmaceutical Company Information
6.5.2 Nanjing Zhengke Pharmaceutical Description and Business Overview
6.5.3 Nanjing Zhengke Pharmaceutical Andrographolide Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Nanjing Zhengke Pharmaceutical Andrographolide Drug Product Portfolio
6.5.5 Nanjing Zhengke Pharmaceutical Recent Developments/Updates
6.6 Livzon Pharm
6.6.1 Livzon Pharm Company Information
6.6.2 Livzon Pharm Description and Business Overview
6.6.3 Livzon Pharm Andrographolide Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Livzon Pharm Andrographolide Drug Product Portfolio
6.6.5 Livzon Pharm Recent Developments/Updates
6.7 HORMOSAN Pharma
6.7.1 HORMOSAN Pharma Company Information
6.7.2 HORMOSAN Pharma Description and Business Overview
6.7.3 HORMOSAN Pharma Andrographolide Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 HORMOSAN Pharma Andrographolide Drug Product Portfolio
6.7.5 HORMOSAN Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Andrographolide Drug Industry Chain Analysis
7.2 Andrographolide Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Andrographolide Drug Production Mode & Process Analysis
7.4 Andrographolide Drug Sales and Marketing
7.4.1 Andrographolide Drug Sales Channels
7.4.2 Andrographolide Drug Distributors
7.5 Andrographolide Drug Customer Analysis
8 Andrographolide Drug Market Dynamics
8.1 Andrographolide Drug Industry Trends
8.2 Andrographolide Drug Market Drivers
8.3 Andrographolide Drug Market Challenges
8.4 Andrographolide Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Andrographolide Drug by Type
1.2.1 Global Andrographolide Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Capsule
1.2.3 Pill
1.2.4 Tablet
1.3 Andrographolide Drug by Application
1.3.1 Global Andrographolide Drug Market Value by Application (2024 VS 2031)
1.3.2 Hospital Clinic
1.3.3 Pharmacy
1.3.4 Online Pharmacy
1.4 Global Andrographolide Drug Market Size Estimates and Forecasts
1.4.1 Global Andrographolide Drug Revenue 2020-2031
1.4.2 Global Andrographolide Drug Sales 2020-2031
1.4.3 Global Andrographolide Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Andrographolide Drug Market Competition by Manufacturers
2.1 Global Andrographolide Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Andrographolide Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Andrographolide Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Andrographolide Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Andrographolide Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Andrographolide Drug, Product Type & Application
2.7 Global Key Manufacturers of Andrographolide Drug, Date of Enter into This Industry
2.8 Global Andrographolide Drug Market Competitive Situation and Trends
2.8.1 Global Andrographolide Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Andrographolide Drug Players Market Share by Revenue
2.8.3 Global Andrographolide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Andrographolide Drug Market Scenario by Region
3.1 Global Andrographolide Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Andrographolide Drug Sales by Region: 2020-2031
3.2.1 Global Andrographolide Drug Sales by Region: 2020-2025
3.2.2 Global Andrographolide Drug Sales by Region: 2026-2031
3.3 Global Andrographolide Drug Revenue by Region: 2020-2031
3.3.1 Global Andrographolide Drug Revenue by Region: 2020-2025
3.3.2 Global Andrographolide Drug Revenue by Region: 2026-2031
3.4 North America Andrographolide Drug Market Facts & Figures by Country
3.4.1 North America Andrographolide Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Andrographolide Drug Sales by Country (2020-2031)
3.4.3 North America Andrographolide Drug Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Andrographolide Drug Market Facts & Figures by Country
3.5.1 Europe Andrographolide Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Andrographolide Drug Sales by Country (2020-2031)
3.5.3 Europe Andrographolide Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Andrographolide Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Andrographolide Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Andrographolide Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Andrographolide Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Andrographolide Drug Market Facts & Figures by Country
3.7.1 Latin America Andrographolide Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Andrographolide Drug Sales by Country (2020-2031)
3.7.3 Latin America Andrographolide Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Andrographolide Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Andrographolide Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Andrographolide Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Andrographolide Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Andrographolide Drug Sales by Type (2020-2031)
4.1.1 Global Andrographolide Drug Sales by Type (2020-2025)
4.1.2 Global Andrographolide Drug Sales by Type (2026-2031)
4.1.3 Global Andrographolide Drug Sales Market Share by Type (2020-2031)
4.2 Global Andrographolide Drug Revenue by Type (2020-2031)
4.2.1 Global Andrographolide Drug Revenue by Type (2020-2025)
4.2.2 Global Andrographolide Drug Revenue by Type (2026-2031)
4.2.3 Global Andrographolide Drug Revenue Market Share by Type (2020-2031)
4.3 Global Andrographolide Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Andrographolide Drug Sales by Application (2020-2031)
5.1.1 Global Andrographolide Drug Sales by Application (2020-2025)
5.1.2 Global Andrographolide Drug Sales by Application (2026-2031)
5.1.3 Global Andrographolide Drug Sales Market Share by Application (2020-2031)
5.2 Global Andrographolide Drug Revenue by Application (2020-2031)
5.2.1 Global Andrographolide Drug Revenue by Application (2020-2025)
5.2.2 Global Andrographolide Drug Revenue by Application (2026-2031)
5.2.3 Global Andrographolide Drug Revenue Market Share by Application (2020-2031)
5.3 Global Andrographolide Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Tasly Group
6.1.1 Tasly Group Company Information
6.1.2 Tasly Group Description and Business Overview
6.1.3 Tasly Group Andrographolide Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Tasly Group Andrographolide Drug Product Portfolio
6.1.5 Tasly Group Recent Developments/Updates
6.2 Furen Pharmaceutical
6.2.1 Furen Pharmaceutical Company Information
6.2.2 Furen Pharmaceutical Description and Business Overview
6.2.3 Furen Pharmaceutical Andrographolide Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Furen Pharmaceutical Andrographolide Drug Product Portfolio
6.2.5 Furen Pharmaceutical Recent Developments/Updates
6.3 Jiuhui Pharmaceutical
6.3.1 Jiuhui Pharmaceutical Company Information
6.3.2 Jiuhui Pharmaceutical Description and Business Overview
6.3.3 Jiuhui Pharmaceutical Andrographolide Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Jiuhui Pharmaceutical Andrographolide Drug Product Portfolio
6.3.5 Jiuhui Pharmaceutical Recent Developments/Updates
6.4 Sunflower Pharmaceutical
6.4.1 Sunflower Pharmaceutical Company Information
6.4.2 Sunflower Pharmaceutical Description and Business Overview
6.4.3 Sunflower Pharmaceutical Andrographolide Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sunflower Pharmaceutical Andrographolide Drug Product Portfolio
6.4.5 Sunflower Pharmaceutical Recent Developments/Updates
6.5 Nanjing Zhengke Pharmaceutical
6.5.1 Nanjing Zhengke Pharmaceutical Company Information
6.5.2 Nanjing Zhengke Pharmaceutical Description and Business Overview
6.5.3 Nanjing Zhengke Pharmaceutical Andrographolide Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Nanjing Zhengke Pharmaceutical Andrographolide Drug Product Portfolio
6.5.5 Nanjing Zhengke Pharmaceutical Recent Developments/Updates
6.6 Livzon Pharm
6.6.1 Livzon Pharm Company Information
6.6.2 Livzon Pharm Description and Business Overview
6.6.3 Livzon Pharm Andrographolide Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Livzon Pharm Andrographolide Drug Product Portfolio
6.6.5 Livzon Pharm Recent Developments/Updates
6.7 HORMOSAN Pharma
6.7.1 HORMOSAN Pharma Company Information
6.7.2 HORMOSAN Pharma Description and Business Overview
6.7.3 HORMOSAN Pharma Andrographolide Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 HORMOSAN Pharma Andrographolide Drug Product Portfolio
6.7.5 HORMOSAN Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Andrographolide Drug Industry Chain Analysis
7.2 Andrographolide Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Andrographolide Drug Production Mode & Process Analysis
7.4 Andrographolide Drug Sales and Marketing
7.4.1 Andrographolide Drug Sales Channels
7.4.2 Andrographolide Drug Distributors
7.5 Andrographolide Drug Customer Analysis
8 Andrographolide Drug Market Dynamics
8.1 Andrographolide Drug Industry Trends
8.2 Andrographolide Drug Market Drivers
8.3 Andrographolide Drug Market Challenges
8.4 Andrographolide Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Andrographolide Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Andrographolide Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Andrographolide Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Andrographolide Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Andrographolide Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Andrographolide Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Andrographolide Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Andrographolide Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Andrographolide Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Andrographolide Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Andrographolide Drug, Product Type & Application
Table 12. Global Key Manufacturers of Andrographolide Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Andrographolide Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Andrographolide Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Andrographolide Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Andrographolide Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Andrographolide Drug Sales Market Share by Region (2020-2025)
Table 19. Global Andrographolide Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Andrographolide Drug Sales Market Share by Region (2026-2031)
Table 21. Global Andrographolide Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Andrographolide Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Andrographolide Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Andrographolide Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Andrographolide Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Andrographolide Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Andrographolide Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Andrographolide Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Andrographolide Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Andrographolide Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Andrographolide Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Andrographolide Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Andrographolide Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Andrographolide Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Andrographolide Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Andrographolide Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Andrographolide Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Andrographolide Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Andrographolide Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Andrographolide Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Andrographolide Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Andrographolide Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Andrographolide Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Andrographolide Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Andrographolide Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Andrographolide Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Andrographolide Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Andrographolide Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Andrographolide Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Andrographolide Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Andrographolide Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Andrographolide Drug Sales Market Share by Type (2020-2025)
Table 53. Global Andrographolide Drug Sales Market Share by Type (2026-2031)
Table 54. Global Andrographolide Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Andrographolide Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Andrographolide Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Andrographolide Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Andrographolide Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global Andrographolide Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global Andrographolide Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Andrographolide Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Andrographolide Drug Sales Market Share by Application (2020-2025)
Table 63. Global Andrographolide Drug Sales Market Share by Application (2026-2031)
Table 64. Global Andrographolide Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Andrographolide Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Andrographolide Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Andrographolide Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Andrographolide Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global Andrographolide Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Tasly Group Company Information
Table 71. Tasly Group Description and Business Overview
Table 72. Tasly Group Andrographolide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Tasly Group Andrographolide Drug Product
Table 74. Tasly Group Recent Developments/Updates
Table 75. Furen Pharmaceutical Company Information
Table 76. Furen Pharmaceutical Description and Business Overview
Table 77. Furen Pharmaceutical Andrographolide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Furen Pharmaceutical Andrographolide Drug Product
Table 79. Furen Pharmaceutical Recent Developments/Updates
Table 80. Jiuhui Pharmaceutical Company Information
Table 81. Jiuhui Pharmaceutical Description and Business Overview
Table 82. Jiuhui Pharmaceutical Andrographolide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Jiuhui Pharmaceutical Andrographolide Drug Product
Table 84. Jiuhui Pharmaceutical Recent Developments/Updates
Table 85. Sunflower Pharmaceutical Company Information
Table 86. Sunflower Pharmaceutical Description and Business Overview
Table 87. Sunflower Pharmaceutical Andrographolide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Sunflower Pharmaceutical Andrographolide Drug Product
Table 89. Sunflower Pharmaceutical Recent Developments/Updates
Table 90. Nanjing Zhengke Pharmaceutical Company Information
Table 91. Nanjing Zhengke Pharmaceutical Description and Business Overview
Table 92. Nanjing Zhengke Pharmaceutical Andrographolide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Nanjing Zhengke Pharmaceutical Andrographolide Drug Product
Table 94. Nanjing Zhengke Pharmaceutical Recent Developments/Updates
Table 95. Livzon Pharm Company Information
Table 96. Livzon Pharm Description and Business Overview
Table 97. Livzon Pharm Andrographolide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Livzon Pharm Andrographolide Drug Product
Table 99. Livzon Pharm Recent Developments/Updates
Table 100. HORMOSAN Pharma Company Information
Table 101. HORMOSAN Pharma Description and Business Overview
Table 102. HORMOSAN Pharma Andrographolide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. HORMOSAN Pharma Andrographolide Drug Product
Table 104. HORMOSAN Pharma Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Andrographolide Drug Distributors List
Table 108. Andrographolide Drug Customers List
Table 109. Andrographolide Drug Market Trends
Table 110. Andrographolide Drug Market Drivers
Table 111. Andrographolide Drug Market Challenges
Table 112. Andrographolide Drug Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Andrographolide Drug
Figure 2. Global Andrographolide Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Andrographolide Drug Market Share by Type: 2024 & 2031
Figure 4. Capsule Product Picture
Figure 5. Pill Product Picture
Figure 6. Tablet Product Picture
Figure 7. Global Andrographolide Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Andrographolide Drug Market Share by Application: 2024 & 2031
Figure 9. Hospital Clinic
Figure 10. Pharmacy
Figure 11. Online Pharmacy
Figure 12. Global Andrographolide Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Andrographolide Drug Market Size (2020-2031) & (US$ Million)
Figure 14. Global Andrographolide Drug Sales (2020-2031) & (K Units)
Figure 15. Global Andrographolide Drug Average Price (US$/Unit) & (2020-2031)
Figure 16. Andrographolide Drug Report Years Considered
Figure 17. Andrographolide Drug Sales Share by Manufacturers in 2024
Figure 18. Global Andrographolide Drug Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Andrographolide Drug Players: Market Share by Revenue in Andrographolide Drug in 2024
Figure 20. Andrographolide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Andrographolide Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Andrographolide Drug Sales Market Share by Country (2020-2031)
Figure 23. North America Andrographolide Drug Revenue Market Share by Country (2020-2031)
Figure 24. United States Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Andrographolide Drug Sales Market Share by Country (2020-2031)
Figure 27. Europe Andrographolide Drug Revenue Market Share by Country (2020-2031)
Figure 28. Germany Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Andrographolide Drug Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Andrographolide Drug Revenue Market Share by Region (2020-2031)
Figure 35. China Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Andrographolide Drug Sales Market Share by Country (2020-2031)
Figure 43. Latin America Andrographolide Drug Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Andrographolide Drug Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Andrographolide Drug Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Andrographolide Drug by Type (2020-2031)
Figure 53. Global Revenue Market Share of Andrographolide Drug by Type (2020-2031)
Figure 54. Global Andrographolide Drug Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Andrographolide Drug by Application (2020-2031)
Figure 56. Global Revenue Market Share of Andrographolide Drug by Application (2020-2031)
Figure 57. Global Andrographolide Drug Price (US$/Unit) by Application (2020-2031)
Figure 58. Andrographolide Drug Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Andrographolide Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Andrographolide Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Andrographolide Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Andrographolide Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Andrographolide Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Andrographolide Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Andrographolide Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Andrographolide Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Andrographolide Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Andrographolide Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Andrographolide Drug, Product Type & Application
Table 12. Global Key Manufacturers of Andrographolide Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Andrographolide Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Andrographolide Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Andrographolide Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Andrographolide Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Andrographolide Drug Sales Market Share by Region (2020-2025)
Table 19. Global Andrographolide Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Andrographolide Drug Sales Market Share by Region (2026-2031)
Table 21. Global Andrographolide Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Andrographolide Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Andrographolide Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Andrographolide Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Andrographolide Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Andrographolide Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Andrographolide Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Andrographolide Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Andrographolide Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Andrographolide Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Andrographolide Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Andrographolide Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Andrographolide Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Andrographolide Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Andrographolide Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Andrographolide Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Andrographolide Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Andrographolide Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Andrographolide Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Andrographolide Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Andrographolide Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Andrographolide Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Andrographolide Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Andrographolide Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Andrographolide Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Andrographolide Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Andrographolide Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Andrographolide Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Andrographolide Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Andrographolide Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Andrographolide Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Andrographolide Drug Sales Market Share by Type (2020-2025)
Table 53. Global Andrographolide Drug Sales Market Share by Type (2026-2031)
Table 54. Global Andrographolide Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Andrographolide Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Andrographolide Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Andrographolide Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Andrographolide Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global Andrographolide Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global Andrographolide Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Andrographolide Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Andrographolide Drug Sales Market Share by Application (2020-2025)
Table 63. Global Andrographolide Drug Sales Market Share by Application (2026-2031)
Table 64. Global Andrographolide Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Andrographolide Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Andrographolide Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Andrographolide Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Andrographolide Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global Andrographolide Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Tasly Group Company Information
Table 71. Tasly Group Description and Business Overview
Table 72. Tasly Group Andrographolide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Tasly Group Andrographolide Drug Product
Table 74. Tasly Group Recent Developments/Updates
Table 75. Furen Pharmaceutical Company Information
Table 76. Furen Pharmaceutical Description and Business Overview
Table 77. Furen Pharmaceutical Andrographolide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Furen Pharmaceutical Andrographolide Drug Product
Table 79. Furen Pharmaceutical Recent Developments/Updates
Table 80. Jiuhui Pharmaceutical Company Information
Table 81. Jiuhui Pharmaceutical Description and Business Overview
Table 82. Jiuhui Pharmaceutical Andrographolide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Jiuhui Pharmaceutical Andrographolide Drug Product
Table 84. Jiuhui Pharmaceutical Recent Developments/Updates
Table 85. Sunflower Pharmaceutical Company Information
Table 86. Sunflower Pharmaceutical Description and Business Overview
Table 87. Sunflower Pharmaceutical Andrographolide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Sunflower Pharmaceutical Andrographolide Drug Product
Table 89. Sunflower Pharmaceutical Recent Developments/Updates
Table 90. Nanjing Zhengke Pharmaceutical Company Information
Table 91. Nanjing Zhengke Pharmaceutical Description and Business Overview
Table 92. Nanjing Zhengke Pharmaceutical Andrographolide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Nanjing Zhengke Pharmaceutical Andrographolide Drug Product
Table 94. Nanjing Zhengke Pharmaceutical Recent Developments/Updates
Table 95. Livzon Pharm Company Information
Table 96. Livzon Pharm Description and Business Overview
Table 97. Livzon Pharm Andrographolide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Livzon Pharm Andrographolide Drug Product
Table 99. Livzon Pharm Recent Developments/Updates
Table 100. HORMOSAN Pharma Company Information
Table 101. HORMOSAN Pharma Description and Business Overview
Table 102. HORMOSAN Pharma Andrographolide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. HORMOSAN Pharma Andrographolide Drug Product
Table 104. HORMOSAN Pharma Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Andrographolide Drug Distributors List
Table 108. Andrographolide Drug Customers List
Table 109. Andrographolide Drug Market Trends
Table 110. Andrographolide Drug Market Drivers
Table 111. Andrographolide Drug Market Challenges
Table 112. Andrographolide Drug Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Andrographolide Drug
Figure 2. Global Andrographolide Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Andrographolide Drug Market Share by Type: 2024 & 2031
Figure 4. Capsule Product Picture
Figure 5. Pill Product Picture
Figure 6. Tablet Product Picture
Figure 7. Global Andrographolide Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Andrographolide Drug Market Share by Application: 2024 & 2031
Figure 9. Hospital Clinic
Figure 10. Pharmacy
Figure 11. Online Pharmacy
Figure 12. Global Andrographolide Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Andrographolide Drug Market Size (2020-2031) & (US$ Million)
Figure 14. Global Andrographolide Drug Sales (2020-2031) & (K Units)
Figure 15. Global Andrographolide Drug Average Price (US$/Unit) & (2020-2031)
Figure 16. Andrographolide Drug Report Years Considered
Figure 17. Andrographolide Drug Sales Share by Manufacturers in 2024
Figure 18. Global Andrographolide Drug Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Andrographolide Drug Players: Market Share by Revenue in Andrographolide Drug in 2024
Figure 20. Andrographolide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Andrographolide Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Andrographolide Drug Sales Market Share by Country (2020-2031)
Figure 23. North America Andrographolide Drug Revenue Market Share by Country (2020-2031)
Figure 24. United States Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Andrographolide Drug Sales Market Share by Country (2020-2031)
Figure 27. Europe Andrographolide Drug Revenue Market Share by Country (2020-2031)
Figure 28. Germany Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Andrographolide Drug Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Andrographolide Drug Revenue Market Share by Region (2020-2031)
Figure 35. China Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Andrographolide Drug Sales Market Share by Country (2020-2031)
Figure 43. Latin America Andrographolide Drug Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Andrographolide Drug Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Andrographolide Drug Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Andrographolide Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Andrographolide Drug by Type (2020-2031)
Figure 53. Global Revenue Market Share of Andrographolide Drug by Type (2020-2031)
Figure 54. Global Andrographolide Drug Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Andrographolide Drug by Application (2020-2031)
Figure 56. Global Revenue Market Share of Andrographolide Drug by Application (2020-2031)
Figure 57. Global Andrographolide Drug Price (US$/Unit) by Application (2020-2031)
Figure 58. Andrographolide Drug Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232